Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.

Endocrine, metabolic & immune disorders drug targets - 1 Jan 2018

Cantore Stefania, Crincoli Vito, Boccaccio Antonio, Uva Antonio E, Fiorentino Michele, Monno Giuseppe, Bollero Patrizio, Derla Chiara, Fabiano Francesca, Ballini Andrea, Santacroce Luigi

Abstract excerpt

BACKGROUND: New sources of stem cells in adult organisms are constantly emerging. Postnatal Mesenchymal Stem Cells (MSCs), are the most promising support to perform an effective regenerative medicine: such cells have the ability to differentiate into several lineages, such as osteoblasts and chondroblasts, providing novel strategies to improve different complex treatments, during bone regeneration. 3D-printed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cells, Cultured
Share to Mesenchymal Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mesenchymal Stem Cells

Share to Phenotype

Share to Regenerative Medicine

Share to Tissue Engineering

Share to Tissue Scaffolds

Source

Identifiers

PMID: 29692270
DOI: 10.2174/1871530318666180423102905

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.PMID 29692270Read ↗

Prospect of Stem Cells in Bone Tissue Engineering: A ReviewSemantic proximity Read ↗

Mesenchymal Stem Cells for Bone Gene Therapy and Tissue EngineeringSemantic proximity Read ↗

Mesenchymal stem cell differentiation and roles in regenerative medicineSemantic proximity Read ↗

Methodology, biology and clinical applications of mesenchymal stem cellsSemantic proximity Read ↗

Mesenchymal stem cells at the intersection of cell and gene therapySemantic proximity Read ↗

Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche.Semantic proximity Read ↗

Biomimetic Culture Strategies for the Clinical Expansion of Mesenchymal Stromal Cells.Semantic proximity Read ↗

Mesenchymal Stem Cells: Biological Characteristics and Potential Clinical ApplicationsSemantic proximity Read ↗

Optimizing Mesenchymal Stromal Cells Delivery: Present Status and New Frontiers in Regenerative MedicineSemantic proximity Read ↗

Mesenchymal stem cells: amazing remedies for bone and cartilage defectsSemantic proximity Read ↗

Three-dimensional printed polycaprolactone-based scaffolds provide an advantageous environment for osteogenic differentiation of human adipose-derived stem cells.Semantic proximity Read ↗

Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.